CH Biotech R&D Co., Ltd. (TPE:6534)

Market Cap	8.66B +1.6%
Revenue (ttm)	1.77B +17.4%
Net Income	439.33M +15.2%
EPS	4.25 +13.2%
Shares Out	102.80M
PE Ratio	19.82
Forward PE	n/a
Dividend	4.10 (4.87%)
Ex-Dividend Date	n/a

Volume	120,316
Average Volume	81,131
Open	84.50
Previous Close	84.10
Day's Range	83.40 - 84.80
52-Week Range	71.10 - 123.50
Beta	0.21
RSI	39.07
Earnings Date	Feb 11, 2026

About CH Biotech R&D

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan.

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 2013
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6534

Financial Performance

In 2024, CH Biotech R&D's revenue was 1.64 billion, an increase of 7.98% compared to the previous year's 1.51 billion. Earnings were 476.39 million, an increase of 2.83%.